Clinical trial
Evaluation of Safety and Efficacy of Remifentanil in Preterm Infant
NCT01477892 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Safety and Efficacy of Remifentanil in Preterm Infant
- Lead sponsor
- Seoul National University Hospital
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 31, 2011
- Completion date
- April 30, 2012
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
infant, preterm